Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Injection Drug Use Is a Risk Factor for HCV Infection in Urban Egypt

  • Adela Paez Jimenez ,

    adelapaez@yahoo.com

    Affiliation Emerging Disease Epidemiology Unit, Institut Pasteur, Paris, France

  • Mostafa K. Mohamed,

    Affiliation Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt

  • Noha Sharaf Eldin,

    Affiliation Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt

  • Hasnaa Abou Seif,

    Affiliation Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt

  • Said El Aidi,

    Affiliation Imbaba Fever Hospital, Cairo, Egypt

  • Yehia Sultan,

    Affiliation Abassaia Fever Hospital, Cairo, Egypt

  • Nasr Elsaid,

    Affiliation Ministry of Health and Population, Cairo, Egypt

  • Claire Rekacewicz,

    Affiliation Emerging Disease Epidemiology Unit, Institut Pasteur, Paris, France

  • Mostafa El-Hoseiny,

    Affiliation Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt

  • May El-Daly,

    Affiliations Viral Hepatitis Research Laboratory, National Hepatology & Tropical Medicine Research Institute, Cairo, Egypt, National Liver Institute, Menoufia University, Menophya, Egypt

  • Mohamed Abdel-Hamid,

    Affiliations Viral Hepatitis Research Laboratory, National Hepatology & Tropical Medicine Research Institute, Cairo, Egypt, Department of Microbiology, Faculty of Medicine, Minia University, Minia, Egypt

  • Arnaud Fontanet

    Affiliation Emerging Disease Epidemiology Unit, Institut Pasteur, Paris, France

Injection Drug Use Is a Risk Factor for HCV Infection in Urban Egypt

  • Adela Paez Jimenez, 
  • Mostafa K. Mohamed, 
  • Noha Sharaf Eldin, 
  • Hasnaa Abou Seif, 
  • Said El Aidi, 
  • Yehia Sultan, 
  • Nasr Elsaid, 
  • Claire Rekacewicz, 
  • Mostafa El-Hoseiny, 
  • May El-Daly
PLOS
x

Abstract

Objective

To identify current risk factors for hepatitis C virus (HCV) transmission in Greater Cairo.

Design and Setting

A 1∶1 matched case-control study was conducted comparing incident acute symptomatic hepatitis C patients in two “fever” hospitals of Greater Cairo with two control groups: household members of the cases and acute hepatitis A patients diagnosed at the same hospitals. Controls were matched on the same age and sex to cases and were all anti-HCV antibody negative. Iatrogenic, community and household exposures to HCV in the one to six months before symptoms onset for cases, and date of interview for controls, were exhaustively assessed.

Results

From 2002 to 2007, 94 definite acute symptomatic HCV cases and 188 controls were enrolled in the study. In multivariate analysis, intravenous injections (OR = 5.0; 95% CI = 1.2–20.2), medical stitches (OR = 4.2; 95% CI = 1.6–11.3), injection drug use (IDU) (OR = 7.9; 95% CI = 1.4–43.5), recent marriage (OR = 3.3; 95% CI = 1.1–9.9) and illiteracy (OR = 3.9; 95% CI = 1.8–8.5) were independently associated with an increased HCV risk.

Conclusion

In urban Cairo, invasive health care procedures remain a source of HCV transmission and IDU is an emerging risk factor. Strict application of standard precautions during health care is a priority. Implementation of comprehensive infection prevention programs for IDU should be considered.

Introduction

The highest HCV prevalence in the world occurs in Egypt at an estimated 12% [1], i.e. 10 to 20 fold higher than in Northern Europe [2] or in the United States [3]. The bulk of chronic infection is age-related [4] and occurs among persons of rural origin. Cohort studies have estimated a 9% prevalence and 0.8/1000 person-years incidence in Upper Egypt, and a 24% prevalence and 6.8/1000 incidence in the Nile Delta [5], [6].

The widespread schistosomiasis treatment campaigns with intravenous tartar emetic, carried out in the countryside in the 60's- early 80's, ignited this epidemic through reuse of insufficiently sterilised needles and syringes [7]. Since then, cross-sectional studies have shown unsafe injection practices, history of blood transfusion, invasive medical procedures, and instrument-assisted birth deliveries as associated with HCV infection [8][10]. Intra-familial transmission may also have played an important role, as evidenced in two recent cohort studies [6], [11].

However, HCV transmission has been studied almost exclusively in rural areas, with only two uncontrolled studies reporting on urban hepatitis C patients [12], [13]. After last decades of large rural exodus leading to the suburbs of Cairo, 45% of the Egyptian population is urban (Source CAPMAS, 2000). In order to identify current risk factors for HCV infection in urban Egypt, we have conducted a case-control study recruiting incident HCV case patients, i.e. recently acquired infections, in two hospitals serving Greater Cairo (Cairo and its suburbs).

Methods

Participants' recruitment and questionnaire

From April 2002 to June 2007, a 1∶1 matched case-control study with two control groups was conducted. Incident acute symptomatic hepatitis C patients were enrolled as cases either (i) before seroconversion, with negative anti-HCV antibody and positive HCV RNA laboratory results or (ii) with rapid seroconversion: positive anti-HCV antibody and positive HCV RNA associated with alanine aminotransferase (ALT) ≥20 times the ULN (≥800 IU/L). The high ALT threshold was used to exclude ALT flares in patients with chronic hepatitis C.

Two control groups were matched on age (±1 year) and sex: household members (family controls) and acute hepatitis A patients (HAV controls) diagnosed at the same hospitals. Only laboratory confirmed anti-HCV negative controls were included in the study.

Since age at infection profile of HAV and HCV are overlapping in the age group between 15–40 years of age, only cases and controls in this age range were considered to allow proper matching.

Acute hepatitis patients were identified at the two ‘fever’ hospitals of Greater Cairo, Abbassia and Imbaba. ‘Fever’ Hospitals are large public and non-paying hospitals whose patient population derives mostly from low socioeconomic groups (methods published elsewhere [12]). In- and outpatients with recent (<3 weeks) symptoms suggestive of hepatitis (fever or jaundice) were invited to participate in the study. After providing written informed consent (from one of the parents if less than 18 years of age), they answered orally administered standardised questionnaires covering socio-demographic characteristics, present and past health conditions, and exposure to potential risk factors for viral hepatitis in the one to six months before onset of illness. Regarding socio-demographic variables, illiteracy (the inability to read and write) and marriage duration (aggregated on recently married versus married for longer than one year) were of special interest.

Other exposures in the one to six months before symptoms onset included a history of invasive medical procedures (e.g., surgery, intravenous catheter, endoscope, blood transfusion, IV drip infusions, injections, haemodialysis, biopsy, endoscope, sclerotherapy of varicose veins), obstetrical procedures (caesarean section, episiotomy, uterine curettage) and dental treatment. Information on the following community–acquired exposures was also collected: circumcision, ear-piercing, shaving at barbershops, sharing razors or nail trimmers with family members, manicure or pedicure at beauty salons, tattooing, and acupuncture. Due to their sensitive nature, questions on high-risk behavior such as alcohol consumption, drug use (e.g., sniffing or intravenous (IDU)) and multiple sexual partners were only asked to men. During counselling, case patients were invited to ask their families to participate in the study. After providing informed consent, family members answered the same questionnaire regarding exposures at risk in the one to 6 months before interview.

Approval for the study was obtained from the Institutional Review Board of the Egyptian Ministry of Population and Health (MoPH) and the Ethics Committee of the National Hepatology and Tropical Medicine Research Institute (NHTMRI, Egypt).

Laboratory testing

A 10 ml venous blood sample was collected. Patients were tested for standard liver functions (ALT), aspartate aminotransferase (AST), total and indirect bilirubin, alkaline phosphatase) and for the following hepatitis markers: anti-HAV IgM (HAVAB®, M EIA, Abbott Laboratories, Diagnostics Division, IL, USA), anti-HBc IgM (CORZYME®, M rDNA, Abbott Laboratories, Diagnostics Division, IL, USA) and HBs antigen (AUSZYME MONOCLONAL®, third generation EIA, Abbott Laboratories, Diagnostics Division, IL, USA). In patients with non-A non-B hepatitis, anti-HCV antibody and HCV-RNA were assessed serologically (INNOTEST® HCV Ab IV, Innogenetics, Ghent, Belgium) and using polymerase chain reaction (PCR) (nested reverse transcriptase PCR by in house assay using 5′ UTR primers) [14] testing, respectively. In patients with positive HCV antibodies and RNA, exacerbation of chronic hepatitis C by other infectious agents was ruled out using reverse transcriptase PCR for HEV-RNA (in house assay using ORF1 and ORF2 primers) and serological testing [anti Epstein-Barr virus (EBV) IgM (ETI-EBV-M reverse P001605, Dia Sorin, Vercelle, Italy), anti-cytomegalovirus (CMV) IgM (AXSYM® system-CMV-IgM, Abbott Laboratories, Wiesbaden, Delknheim, Germany), and anti-Toxoplasma IgM (AXSYM® system-Toxo-IgM, Abbott Laboratories, Wiesbaden, Delknheim, Germany)].

Family controls were anti-HCV antibody and HCV-RNA tested using the same techniques.

Statistical analysis

Univariate ORs and 95% confidence intervals (95% CI) were estimated for each potential risk factor using a conditional logistic regression model (to account for the matched design) and significance was assessed by the Wald test. Interactions were tested by introducing interaction terms in the model.

Since both control groups had the same odds of exposures for most exposures, as can be seen in Tables 1 to 3, we believe that they were properly sampling the same source population of cases, i.e., those who would have gone for care at the fever hospitals had they developed acute hepatitis C. As a result, we decided to group them to increase the study power.

thumbnail
Table 1. Socio-demographic characteristics of acute hepatitis C cases and controls sex- and ±1 year age-matched, Greater Cairo, 2002-7.

https://doi.org/10.1371/journal.pone.0007193.t001

thumbnail
Table 2. Health care related risk factors among acute hepatitis C cases and controls sex- and ±1 year age-matched, Greater Cairo, 2002-7.

https://doi.org/10.1371/journal.pone.0007193.t002

thumbnail
Table 3. Community exposures and high risk habits among acute hepatitis C cases and controls sex- and ±1 year age-matched, Greater Cairo, 2002-7.

https://doi.org/10.1371/journal.pone.0007193.t003

Variables with p-values<0.20 were entered into a multivariate conditional logistic regression model to simultaneously examine their independent effect. The final model was obtained through stepwise deletion of variables until all predictors left had p-values<0.05.

With this sample size, the study had an 80% power to document odds ratios (OR) above 2.0 for exposures present among 50% of controls, and 3.5 for exposures present among 5% of controls (α = 0.05; two-sided tests).

Data were analyzed using STATA 9.0 software (Stata Corporation, College Station, USA).

Results

Description of the study population

Ninety four cases and their 188 controls, 94 HAV controls and 94 family controls, were enrolled in the study. Mean age (±SD) of the cases was 25.9 (±5.9) years and 70% (n = 66) were males.

Case patients being symptomatic by definition, the prevalence of symptoms was the following: fever (44.7%), jaundice (95.7%), light clay stools (87.2%), dark urine (96.8%), abdominal pain (82.9%) and vomiting (63.8%). The median bilirubin level (mg/dL) was 7.2 (Interquartile range (IQR) = 4.7–11) and the median ALT level (IU/L) was 884 (IQR = 625-1350). As expected due to matching design, mean age and male proportion were similar between cases and controls (Table 1). Prevalences of exposure to studied risk factors were also similar between the two control groups, as shown in Tables 1 to 3.

Matched analysis

In univariate analysis, iatrogenic factors (Table 2) statistically associated with HCV infection were history of hospitalization, having major surgery, receiving wound stitches in emergency rooms, intravenous (IV) cannula, and IV injections but not intramuscular injections. In women, child birth and caesarean section were associated with increased risk of HCV infection, although the association was marginally significant for delivery (p = 0.06).

Dental treatment, even if quite common (16.5% of the control population), was not associated with increased risk of infection. This remained true after studying various dental procedures (tooth extraction, gum treatment, cavity filling and dental anaesthesia) separately.

Also in univariate analysis, illiteracy and marriage were associated with HCV transmission (Table 3). None of the community-acquired exposures showed a significant increase in HCV risk but all of studied high risk habits were associated with increases in HCV risk: drinking alcohol (OR = 2.6; 95% CI = 1.3–5.3), multiple sexual partners (OR = 3.5; 95% CI = 1.1–11.6) and IDU (OR = 8.5; 95% CI = 2.1–33.8) as well as sniffing drugs (OR = 3.6; 95% CI = 1.5–8.4).

Among the factors that could not be evaluated for their significance due to low exposure prevalence were hospitalization in intensive care unit, IV catheter, endoscope, laparoscopy, ascites tapping, biopsy, schlerotherapy for varicose, electromyogram and blood transfusion.

In multivariate analysis (Table 4), the following risk factors were independently associated with an increase in HCV risk: therapeutic intravenous injections (OR = 5.0; 95% CI = 1.2–20.2), medical stitches (OR = 4.2; 95% CI = 1.6–11.3), sniffing illicit drugs (OR = 4.4; 95% CI = 1.6–12.1) and injection drug use (OR = 7.9; 95% CI = 1.4–43.5). Being recently married versus being single (OR = 3.3; 95% CI = 1.1–9.9), and being illiterate (OR = 3.9; 95% CI = 1.8–8.5) were also associated with HCV transmission.

thumbnail
Table 4. Multivariate analysis showing factors independently associated with acute hepatitis C, Greater Cairo, 2002-7.

https://doi.org/10.1371/journal.pone.0007193.t004

Discussion

In this study, three risk factors reflecting direct mechanisms of HCV transmission have been associated with HCV infection: illicit drug use, unsafe therapeutic injections and wound stitches. In addition, illiteracy and recent marriage, indirect mechanisms of transmission, were also independently associated with HCV infection. A key strength of this study is the recruitment of incident cases, allowing detailed assessment of exposures in a well-defined time period, the one to six months prior to onset of symptoms. Many published cross-sectional studies have compared individuals with and without anti-HCV antibodies to identify risk factors for infection [10], [15], [16]. These studies, although based on large numbers, suffered from drawbacks such as approximate exposure assessment over long periods of time, and the possibility that exposures followed, rather than antedated, HCV infection. Case-control studies offer a better design but still information and selection bias may happen. Regarding information bias, questionnaires in this study were administered at the time patients presented to the hospital, and prior to knowing whether they had acute hepatitis C or acute hepatitis A. Therefore, chances that the interviewer would be biased in recording exposure information for these two groups were minimised. Regarding selection bias is expected to be low since both series of controls were chosen so that they were “likely to have consulted at the study hospitals had they developed the disease of interest”, and both gave very similar prevalence estimates for all the exposures under study. Finally, our strict (±1 year) age- and gender matching maximised study power when it came to control for important potential confounders such as age and gender.

Acute infection with HCV leads to symptomatic hepatitis only in ∼15% of patients and it is most often diagnosed in the setting of post-exposure surveillance or seroconversion in high risk individuals (e.g., healthcare professionals or injecting drug users) [17]. One may wonder whether focusing on symptomatic cases might have biased the study towards the identification of risk factors more prone to lead to symptomatic forms of infection. However, we have not found in the literature evidence of factors associated with symptomatic forms of infection, except for older age [18].

Of interest, partial genotyping information is available for some patients with acute hepatitis C recruited in the same hospitals: 11 of 12 patients who underwent treatment after 4–6 months of persistent infection were infected with HCV genotype 4 [19]. And 10 out of 12 of our acute HCV participants involved in a study of HCV intrafamilial transmission were infected with genotype 4 (Paez Jimenez, personal communication). Others were infected with genotype 1. These findings are in line with the known predominance of genotype 4 among HCV-infected Egyptian subjects [20].

This study supported the important role played by invasive health care procedures in HCV transmission in this population. Intravenous injections in the past six months were associated with a five-fold increase in HCV risk in multivariate analysis. Conversely, intramuscular injections, although very common (16.0% of the control population), were not associated with any increase in HCV risk, suggesting that large hollow-bore needles, and intravenous placement of needles, are important contributors to the efficiency of HCV transmission [21]. Similarly, stitches, which involve repeated percutaneous effractions of the skin with the same needle, proved to be efficient in transmitting HCV. Other invasive medical procedures, such as endoscope, laparoscopy, or blood transfusions, were not associated with increased risk of HCV transmission, largely as a result of very low numbers of exposed individuals, limiting the possibility of estimating risks with sufficient precision. While this does not preclude increased risk of transmission associated with each procedure, it does suggest that these procedures contribute little to the HCV spread in this population, considering the very limited number of exposed individuals. Of interest, dental care, previously associated with HCV spread in Southern Italy [22] and although commonly reported, was not associated with increased risk of HCV transmission in our study. Neither were community exposures such as shaving at barbershop, circumcision, ear-piercing, tattooing, manicure or pedicure previously reported at risk in other regions [23][25], [26].

In high prevalence areas, contaminated medical equipment seems to be a common HCV thread [4]. Injecting drug use, leading HCV mode of transmission in low prevalence countries, has emerged in our study as a HCV risk factor in Greater Cairo. In wealthy regions [27] but also in Thailand [28], China [29], Iran [30] or Afghanistan [31], IDUs are suffering an HCV hyperendemia with HCV prevalence rates of 48–96%, due to the collective use of injecting equipment (and drug solution) and the turnover in injection partners [32] with a higher risk of acquiring HCV shortly after onset of injection (after 5 years, 50–90% of users have been exposed to HCV) [33]. In our study, intranasal drug users were also at increased risk of acquiring HCV. Sniffing has been previously identified as a HCV risk factor [34], [35] and HCV has been detected in nasal secretions [36], [37] but evidence is not consistent in all studies [38]. This association in our results could be due to IDUs reporting sniffing instead injecting practices. In any case, the high proportion of illicit drug use (11% of male controls, since women were not asked) is most probably a particularity of urban Egypt compared to rural Egypt. Scale-up of harm reduction interventions is urgently needed in Greater Cairo. This will serve not only the control of the HCV epidemic, but also that of other feared blood-borne agents such as HBV or the human immunodeficiency virus (HIV).

More puzzling is the association found between marriage and HCV infection, and particularly recent marriage. Previous studies in Egypt and elsewhere in the world gave contradictory findings regarding the risk of HCV transmission between spouses. In rural areas of Egypt, Magder et al. estimated through mathematical modelling that 6% of infected individuals acquired infection from their spouses [39]. On the other hand, cohort studies in Italy and Turkey found very low rates of intra-spousal transmission of HCV over several years of follow-up per couple [40], [41]. In this study, the risk of HCV transmission was higher during the first year of marriage, and decreased afterwards. One way to reconcile the above-mentioned findings would be to consider that upon first encounters with an HCV-infected spouse, the most susceptible individuals would become infected, while others would remain little susceptible to infection for the rest of their lives. Cohort studies, which exclude couples with both spouses already infected at baseline, would only follow less susceptible individuals, hence documenting very low rates of transmission. Unfortunately, the study was not able to identify the modes of transmission (e.g., sexual, exchange of grooming items) that may have contributed to inter-spouse transmission, hence limiting the scope of prevention messages that can be formulated at this stage.

The HCV increased risk related with illiteracy is worth mentioning. Although previously reported [42][44], one may have argued that this association was the result of using an improper control group with hepatitis A patients. Indeed, developing hepatitis A as an adolescent or young adult, as for controls recruited in this study, rather than during early childhood, is associated with higher standards of hygiene, and presumably higher socio-economical status. Hence, the hepatitis A control group might have been “over educated” and the acute hepatitis C group then more likely to belong to lower educational status. However, comparison with a matched group issued from relatives of hepatitis C patients also revealed the same difference in illiteracy, suggesting that low education is genuinely associated with increased risk of HCV infection. Since the OR associated with illiteracy was little modified by control for at risk exposures in multivariate analysis, one may assume that important risk practices associated with low education were not measured in this study. Then, illiteracy may reflect an increased vulnerability due to inadequacy of interpersonal networks providing support [42], [43], [45]. In this sense, it speaks for health education campaigns to be target in priority to the most deprived populations.

To conclude, these findings add to the evidence for the need to reinforce policies on HCV risk reduction in health care settings and, for the first time, suggest illicit drug use as an important HCV risk factor in urban Egypt. Effective HCV prevention programming should focus on availability of supplies, safe equipment and contaminated waste disposal in addition to adherence to universal precautions in all health care settings. Campaigns to discourage people from illicit drug consumption and harm-reduction measures such as access to sterile injection equipment or drug dependence treatment are also necessary. With increasingly effective anti-HCV therapy, coordinated mass media campaigns segmented by audience to raise awareness, promote public debate and reduce stigma towards HCV infected persons should be considered.

Acknowledgments

We are indebted to: i) Pauline Leclerc for programming in R random selection of age and sex-matched controls among the pool of suitable ones; ii) Hala Mansour for meticulous monitoring of the laboratory work; iii) Elisabeth Delarocque-Astagneau and Sylvia Taylor for useful advise and detailed revision of the manuscript; iv) The clinicians and the non-medical staff at Abassia and Imbaba hospitals for help with patient recruitment and follow-up; v) The egyptian Ministry of Population and Health for their collaboration and involvement on implementation of the recommendations; vi) The study participants for their time and trust.

Author Contributions

Conceived and designed the experiments: APJ MKM NSE NE CR AF. Performed the experiments: MED. Analyzed the data: APJ MKM HAS MEH MAH AF. Contributed reagents/materials/analysis tools: APJ MKM SEA YS MED MAH AF. Wrote the paper: APJ MKM NSE HAS SEA YS NE CR MEH MED MAH AF.

References

  1. 1. Marzouk D, Sass J, Bakr I, El Hosseiny M, Abdel-Hamid M, et al. (2007) Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut 56: 1105–1110.
  2. 2. Esteban JI, Sauleda S, Quer J (2008) The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 48: 148–162.
  3. 3. Alter MJ (2002) Prevention of spread of hepatitis C. Hepatology 36: S93–98.
  4. 4. Alter MJ (2007) Epidemiology of hepatitis C virus infection. World J Gastroenterol 13: 2436–2441.
  5. 5. Abdel-Aziz F, Habib M, Mohamed MK, Abdel-Hamid M, Gamil F, et al. (2000) Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 32: 111–115.
  6. 6. Mohamed MK, Abdel-Hamid M, Mikhail NN, Abdel-Aziz F, Medhat A, et al. (2005) Intrafamilial transmission of hepatitis C in Egypt. Hepatology 42: 683–687.
  7. 7. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, et al. (2000) The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355: 887–891.
  8. 8. Stoszek SK, Abdel-Hamid M, Narooz S, El Daly M, Saleh DA, et al. (2006) Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women. Trans R Soc Trop Med Hyg 100: 102–107.
  9. 9. Arafa N, El Hoseiny M, Rekacewicz C, Bakr I, El-Kafrawy S, et al. (2005) Changing pattern of hepatitis C virus spread in rural areas of Egypt. J Hepatol 43: 418–424.
  10. 10. Habib M, Mohamed MK, Abdel-Aziz F, Magder LS, Abdel-Hamid M, et al. (2001) Hepatitis C virus infection in a community in the Nile Delta: risk factors for seropositivity. Hepatology 33: 248–253.
  11. 11. Plancoulaine S, Mohamed MK, Arafa N, Bakr I, Rekacewicz C, et al. (2008) Dissection of familial correlations in Hepatitis C Virus (HCV) seroprevalence suggests evidence for intrafamilial viral transmission and genetic predisposition to infection. Gut.
  12. 12. El Gaafary MM, Rekacewicz C, Abdel-Rahman AG, Allam MF, El Hosseiny M, et al. (2005) Surveillance of acute hepatitis C in Cairo, Egypt. J Med Virol 76: 520–525.
  13. 13. Zakaria S, Fouad R, Shaker O, Zaki S, Hashem A, et al. (2007) Changing patterns of acute viral hepatitis at a major urban referral center in Egypt. Clin Infect Dis 44: e30–36.
  14. 14. Abdel-Hamid M, Edelman DC, Highsmith WE, Constantine NT (1997) Optimization, assessment, and proposed use of a direct nested reverse transcription-polymerase chain reaction protocol for the detection of hepatitis C virus. J Hum Virol 1: 58–65.
  15. 15. Medhat A, Shehata M, Magder LS, Mikhail N, Abdel-Baki L, et al. (2002) Hepatitis c in a community in Upper Egypt: risk factors for infection. Am J Trop Med Hyg 66: 633–638.
  16. 16. Nafeh MA, Medhat A, Shehata M, Mikhail NN, Swifee Y, et al. (2000) Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey. Am J Trop Med Hyg 63: 236–241.
  17. 17. Maheshwari A, Ray S, Thuluvath PJ (2008) Acute hepatitis C. Lancet 372: 321–332.
  18. 18. Fabris P, Fleming VM, Giordani MT, Barnes E (2008) Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection. Curr Pharm Des 14: 1661–1665.
  19. 19. Sharaf Eldin N IS, Mansour H, Rekacewicz C, El-Houssinie M, El-Kafrawy S, El Aidi S, Abdel-Hamid M, Esmat G, Pol S, Fontanet A, Mohamed MK (2000) Symptomatic acute hepatitis C in Egypt: diagnosis, spontaneous viral clearance, and delayed treatment with 12 weeks of pegylated interferon alfa-2a. Plos ONE 3:
  20. 20. Abdel-Hamid M, El-Daly M, Molnegren V, El-Kafrawy S, Abdel-Latif S, et al. (2007) Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma. J Gen Virol 88: 1526–1531.
  21. 21. Yazdanpanah Y, De Carli G, Migueres B, Lot F, Campins M, et al. (2005) Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study. Clin Infect Dis 41: 1423–1430.
  22. 22. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, et al. (1997) Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 26: 1006–1011.
  23. 23. Mariano A, Mele A, Tosti ME, Parlato A, Gallo G, et al. (2004) Role of beauty treatment in the spread of parenterally transmitted hepatitis viruses in Italy. J Med Virol 74: 216–220.
  24. 24. Bari A, Akhtar S, Rahbar MH, Luby SP (2001) Risk factors for hepatitis C virus infection in male adults in Rawalpindi-Islamabad, Pakistan. Trop Med Int Health 6: 732–738.
  25. 25. el-Sadawy M, Ragab H, el-Toukhy H, el-Mor Ael L, Mangoud AM, et al. (2004) Hepatitis C virus infection at Sharkia Governorate, Egypt: seroprevalence and associated risk factors. J Egypt Soc Parasitol 34: 367–384.
  26. 26. Karmochkine M, Carrat F, Dos Santos O, Cacoub P, Raguin G (2006) A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection. J Viral Hepat 13: 775–782.
  27. 27. Edlin BR, Carden MR (2006) Injection drug users: the overlooked core of the hepatitis C epidemic. Clin Infect Dis 42: 673–676.
  28. 28. Thaikruea L, Thongsawat S, Maneekarn N, Netski D, Thomas DL, et al. (2004) Risk factors for hepatitis C virus infection among blood donors in northern Thailand. Transfusion 44: 1433–1440.
  29. 29. Garten RJ, Lai S, Zhang J, Liu W, Chen J, et al. (2004) Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol 33: 182–188.
  30. 30. Hajiani E, Hashemi J, Masjedizadeh R, Shayesteh AA, Idani E, et al. (2006) Seroepidemiology of hepatitis C and its risk factors in Khuzestan Province, south-west of Iran: a case-control study. World J Gastroenterol 12: 4884–4887.
  31. 31. Todd CS, Abed AM, Strathdee SA, Scott PT, Botros BA, et al. (2007) HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan. Emerg Infect Dis 13: 1327–1331.
  32. 32. Brewer DD, Hagan H, Sullivan DG, Muth SQ, Hough ES, et al. (2006) Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors. J Infect Dis 194: 764–772.
  33. 33. Hagan H, Thiede H, Des Jarlais DC (2004) Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion. Epidemiology 15: 543–549.
  34. 34. Alavian SM, Gholami B, Masarrat S (2002) Hepatitis C risk factors in Iranian volunteer blood donors: a case-control study. J Gastroenterol Hepatol 17: 1092–1097.
  35. 35. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, et al. (1996) Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 334: 1691–1696.
  36. 36. McMahon JM, Simm M, Milano D, Clatts M (2004) Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user. Ann Clin Microbiol Antimicrob 3: 6.
  37. 37. Aaron S, McMahon JM, Milano D, Torres L, Clatts M, et al. (2008) Intranasal transmission of hepatitis C virus: virological and clinical evidence. Clin Infect Dis 47: 931–934.
  38. 38. Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, et al. (2000) Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology 31: 756–762.
  39. 39. Magder LS, Fix AD, Mikhail NN, Mohamed MK, Abdel-Hamid M, et al. (2005) Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence data. Int J Epidemiol 34: 160–165.
  40. 40. Vandelli C, Renzo F, Romano L, Tisminetzky S, De Palma M, et al. (2004) Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol 99: 855–859.
  41. 41. Tahan V, Karaca C, Yildirim B, Bozbas A, Ozaras R, et al. (2005) Sexual transmission of HCV between spouses. Am J Gastroenterol 100: 821–824.
  42. 42. Akhtar S, Younus M, Adil S, Jafri SH, Hassan F (2004) Hepatitis C virus infection in asymptomatic male volunteer blood donors in Karachi, Pakistan. J Viral Hepat 11: 527–535.
  43. 43. Brandao AB, Fuchs SC (2002) Risk factors for hepatitis C virus infection among blood donors in southern Brazil: a case-control study. BMC Gastroenterol 2: 18.
  44. 44. Talaat M, Kandeel A, Rasslan O, Hajjeh R, Hallaj Z, et al. (2006) Evolution of infection control in Egypt: achievements and challenges. Am J Infect Control 34: 193–200.
  45. 45. Gates JA, Post JJ, Kaldor JM, Pan Y, Haber PS, et al. (2004) Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia. J Urban Health 81: 448–452.